FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Weinblatt

Research Profile

Disorders

Rheumatoid Arthritis

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Joints

Co-author Network

Publications

TOP 3
Thierry Dervieux; Alan Kivitz; Michael E Weinblatt; Joel M Kremer
Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis.
Michael E Weinblatt; Theresa K Musser; Mark C Genovese; Elliott B Grossbard; David A Jones; Arthur Kavanaugh; Daniel B Magilavy
Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.
Siri Lillegraven; Nina Paynter; Femke H M Prince; Nancy A Shadick; Michelle L Frits; Espen A Haavardsholm; Christine K Iannaccone; Tore K Kvien; Michael E Weinblatt; Daniel H Solomon
Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Weinblatt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thierry Dervieux; Alan Kivitz; Michael E Weinblatt; Joel M Kremer
Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis.
Annals of the rheumatic diseases 2013;72(6):908-10.
2013: Michael E Weinblatt; Theresa K Musser; Mark C Genovese; Elliott B Grossbard; David A Jones; Arthur Kavanaugh; Daniel B Magilavy
Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.
The Journal of rheumatology 2013;40(4):369-78.
2013: Siri Lillegraven; Nina Paynter; Femke H M Prince; Nancy A Shadick; Michelle L Frits; Espen A Haavardsholm; Christine K Iannaccone; Tore K Kvien; Michael E Weinblatt; Daniel H Solomon
Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.
Arthritis care & research 2013;65(4):526-33.
2013: Michael E Weinblatt; John Cush; Jenny Devenport; Joel Kremer; Denise Lepley; William Rigby; Natasha Singh; Lichen L Teng; Mark C Genovese
Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: twenty-four-week results of an open-label, clinical practice study.
Arthritis care & research 2013;65(3):362-71.
2013: Michael E Weinblatt; Daniel Baker; Clifton O Bingham; Lilianne Kim; Jiandong Lu; Michael Mack; Alan M Mendelsohn; Rene Westhovens
Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial.
Annals of the rheumatic diseases 2013;72(3):381-9.
2013: Michael Centola; David Chernoff; John P Carulli; Guy Cavet; Douglas J Haney; Lyndal K Hesterberg; Nicholas Knowlton; Saroja Ramanujan; Nancy A Shadick; Yijing Shen; Dustin R Smith; Chris Sutton; Kathryn A Swan; Peter C Taylor; Mary Turner; Michael E Weinblatt; Jeffrey R Curtis
Development of a multi-biomarker disease activity test for rheumatoid arthritis.
PloS one 2013;8(4):e60635.
2013: Michael E Weinblatt; Cathy Zhao; Gustavo Citera; Michael Maldonado; Michael Schiff; Robert Valente; Désirée van der Heijde; Roy Fleischmann
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.
Arthritis and rheumatism 2013;65(1):28-38.
2012: Michael E Weinblatt; Jürgen Wollenhaupt; Clifton O Bingham; Owen R Davies; Ben Duncan; Paul Emery; Roy Fleischmann; Niti Goel; Tom W J Huizinga; Elena M Massarotti; Janet Pope; Ronald F van Vollenhoven; Maxime Dougados
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.
Rheumatology (Oxford, England) 2012;51(12):2204-14.
2012: Jeffrey R Curtis; Roy Fleischmann; Kerri Ford; Max Hamburger; Douglas J Haney; Lyndal K Hesterberg; Tom W Huizinga; Edward Keystone; Rachel Knevel; Saroja Ramanujan; Nancy A Shadick; Yijing Shen; Annette H van der Helm-van Mil; Guy Cavet; Michael Centola; David Chernoff; Michael E Weinblatt
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
Arthritis care & research 2012;64(12):1794-803.
2012: Kevin L Winthrop; Michael E Weinblatt; Charles L Daley
You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need.
Annals of the rheumatic diseases 2012;71(11):1757-60.
2012: Siri Lillegraven; Bing Lu; Femke H M Prince; Nancy A Shadick; Vivian P Bykerk; Michelle L Frits; Espen A Haavardsholm; Christine K Iannaccone; Tore K Kvien; Michael E Weinblatt; Daniel H Solomon
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Annals of the rheumatic diseases 2012;71(5):681-6.
2012: Femke H M Prince; Nancy A Shadick; Michael E Weinblatt; Vivian P Bykerk; Jing Cui; Michelle Frits; Christine K Iannaccone; Bing Lu; Daniel H Solomon
Sustained rheumatoid arthritis remission is uncommon in clinical practice.
Arthritis research & therapy 2012;14(2):R68.
2012: Altan Ercan; Peter Gregersen; Melissa M Hazen; David M Lee; Louise Royle; Pauline M Rudd; Nancy A Shadick; Michael E Weinblatt; Franak Batliwalla; Jonathan S Coblyn; Jing Cui; Peter A Nigrovic
Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis.
Arthritis research & therapy 2012;14(2):R43.
2011: Katherine P Liao; Bing Lu; Nancy A Shadick; Lori B Chibnik; Jonathan S Coblyn; Jing Cui; Christine Iannaccone; Michael E Weinblatt; Daniel H Solomon
Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study.
Rheumatology (Oxford, England) 2011;50(8):1473-9.
2011: Janet S Lee; Mitchell Martin; Robert Pilson; Adam Platt; Olivia Spleiss; Jianmei Wang; Michael E Weinblatt; Ryma Benayed; Soren Germer; Andrew Hemmings; Neil Kaplowitz; Andrew Kenwright; Joel Krasnow
Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
Pharmacogenetics and genomics 2011;21(7):365-74.
2011: Katherine P Liao; Michael E Weinblatt; Daniel H Solomon
The end of rheumatoid factor as we know it?
Arthritis and rheumatism 2011;63(5):1170-2.
2011: Edward C Keystone; Arthur Kavanaugh; Michael E Weinblatt; Kaushik Patra; Aileen L Pangan
Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritis.
The Journal of rheumatology 2011;38(5):855-62.
2011: Mark C Genovese; Stanley B Cohen; David Wofsy; Michael E Weinblatt; Gary S Firestein; Ernest Brahn; Vibeke Strand; Daniel G Baker; Sandra E Tong
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.
The Journal of rheumatology 2011;38(5):846-54.
2011: Derrick J Todd; Nicholas Knowlton; Michael Amato; Mark Barton Frank; Peter H Schur; Elena S Izmailova; Ronenn Roubenoff; Nancy A Shadick; Michael E Weinblatt; Michael Centola; David M Lee
Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor.
Arthritis and rheumatism 2011;63(4):894-903.
2011: Michael E Weinblatt; Joan M Bathon; Scott W Baumgartner; Roy M Fleischmann; Joel M Kremer; Edward L Mancini; Richard W Martin; Grace S Park; Michael H Schiff; Mark C Genovese
Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis.
Arthritis care & research 2011;63(3):373-82.
2011: Mark C Genovese; Arthur Kavanaugh; Michael E Weinblatt; Charles Peterfy; Julie DiCarlo; Michael L White; Maryann O'Brien; Elliott B Grossbard; Daniel B Magilavy
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.
Arthritis and rheumatism 2011;63(2):337-45.
2011: Michael E Weinblatt; Edward C Keystone; Marc D Cohen; Bruce Freundlich; Juan Li; Yun Chon; Scott W Baumgartner
Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
The Journal of rheumatology 2011;38(2):242-6.
2011: Yvonne C Lee; Bing Lu; Nancy A Shadick; Jing Cui; Michelle L Frits; Christine K Iannaccone; Michael E Weinblatt; Daniel H Solomon
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
Arthritis research & therapy 2011;13(3):R83.
2011: Seo Young Kim; Helen Mogun; Jennifer M Polinski; Amber Servi; Jeffrey N Katz; Michael E Weinblatt; Daniel H Solomon
Validation of rheumatoid arthritis diagnoses in health care utilization data.
Arthritis research & therapy 2011;13(1):R32.
2011: Christine K Iannaccone; Yvonne C Lee; Jing Cui; Michelle L Frits; Roberta Glass; Robert M Plenge; Daniel H Solomon; Michael E Weinblatt; Nancy A Shadick
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.
Rheumatology (Oxford, England) 2011;50(1):40-6.
2010: Wenfeng Tan; Hui Wu; Jian Zhao; Lezlie A Derber; David M Lee; Nancy A Shadick; Doyt L Conn; Edwin A Smith; Vivian H Gersuk; Gerald Nepom; Larry W Moreland; Daniel E Furst; Susan D Thompson; Beth L Jonas; V Michael Holers; David N Glass; Pojen P Chen; S Louis Bridges; Michael E Weinblatt; Harold E Paulus; Betty P Tsao
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.
Arthritis and rheumatism 2010;62(10):2864-75.
2010: Michael E Weinblatt; Arthur Kavanaugh; Mark C Genovese; Theresa K Musser; Elliott B Grossbard; Daniel B Magilavy
An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.
The New England journal of medicine 2010;363(14):1303-12.
2010: Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted R Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.
Seminars in arthritis and rheumatism 2010;40(1):2-14.e1.
2010: Eric Boilard; Ying Lai; Katherine Larabee; Barbara Balestrieri; Farideh Ghomashchi; Daisuke Fujioka; Reuben Gobezie; Jonathan S Coblyn; Michael E Weinblatt; Elena M Massarotti; Thomas S Thornhill; Maziar Divangahi; Heinz Remold; Gérard Lambeau; Michael H Gelb; Jonathan P Arm; David M Lee
A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.
EMBO molecular medicine 2010;2(5):172-87.
2010: Sonali P Desai; Ellen M Gravallese; Nancy A Shadick; Roberta Glass; Jing Cui; Michelle Frits; Lori B Chibnik; Nancy Maher; Michael E Weinblatt; Daniel H Solomon
Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA.
Rheumatology (Oxford, England) 2010;49(3):513-9.
2010: Eric Boilard; Peter A Nigrovic; Katherine Larabee; Gerald F M Watts; Jonathan S Coblyn; Michael E Weinblatt; Elena M Massarotti; Eileen Remold-O'Donnell; Richard W Farndale; Jerry Ware; David M Lee
Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.
Science (New York, N.Y.) 2010;327(5965):580-3.
2010: Daniel E Furst; Edward C Keystone; Roy Fleischmann; Philip J Mease; Ferdinand C Breedveld; JS Smolen; JR Kalden; Jonathan Braun; B Bresnihan; Gerd R Burmester; de benedetti fabrizio; T Dörner; P Emery; Allan Gibofsky; Arthur F Kavanaugh; B Kirkham; Michael H Schiff; J Sieper; N Singer; P L C M van Riel; Michael E Weinblatt; Michael H Weisman; Kevin L Winthrop
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.
Annals of the rheumatic diseases 2010;69 Suppl 1():i2-29.
2009: Steven C Greenway; Alexandre C Pereira; Jennifer C Lin; Steven R Depalma; Samuel J Israel; Sonia M Mesquita; Emel Ergul; Jessie H Conta; Joshua M Korn; Steven A McCarroll; Joshua M Gorham; Stacey Gabriel; David Altshuler; Maria de Lourdes Quintanilla-Dieck; Maria Alexandra Artunduaga; Roland D Eavey; Robert M Plenge; Nancy A Shadick; Michael E Weinblatt; Philip De Jager; David A Hafler; Roger E Breitbart; Jonathan G Seidman; Christine E Seidman
De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.
Nature genetics 2009;41(8):931-5.
2009: Daniel H Solomon; Joel S Finkelstein; Nancy A Shadick; Meryl Leboff; Carl S Winalski; Margaret Stedman; Roberta Glass; Maurice Brookhart; Michael E Weinblatt; Ellen M Gravallese
The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.
Arthritis and rheumatism 2009;60(6):1624-31.
2009: Matthew L Stoll; Daniel H Solomon; Kerri L Batra; Julia F Simard; Elizabeth W Karlson; Paul F Dellaripa; Michael E Weinblatt; Roberta Glass; Nancy A Shadick
TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009;15(4):198-200.
2009: Yvonne C Lee; Jing Cui; Karen H Costenbader; Nancy A Shadick; Michael E Weinblatt; Elizabeth W Karlson
Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
Rheumatology (Oxford, England) 2009;48(6):613-7.
2009: Michael E Weinblatt; Gerald F Abbott; Aashiyana F Koreishi
Case records of the Massachusetts General Hospital. Case 13-2009. A 54-year-old woman with respiratory failure and a cavitary lesion in the lung.
The New England journal of medicine 2009;360(17):1770-9.
2009: Samuel M Behar; Daniel S Shin; Agnes Maier; Jonathan S Coblyn; Simon M Helfgott; Michael E Weinblatt
Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
The Journal of rheumatology 2009;36(3):546-51.
2008: Daniel E Furst; Edward C Keystone; B Kirkham; A Kavanaugh; Roy Fleischmann; Philip J Mease; Ferdinand C Breedveld; JS Smolen; JR Kalden; Gerd R Burmester; J Braun; P Emery; Kevin L Winthrop; B Bresnihan; de benedetti fabrizio; T Dörner; Allan Gibofsky; Michael H Schiff; J Sieper; N Singer; P L C M van Riel; Michael E Weinblatt; Michael H Weisman
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Annals of the rheumatic diseases 2008;67 Suppl 3():iii2-25.
2008: Michael E Weinblatt; Arthur Kavanaugh; Ruben Burgos-Vargas; Ara H Dikranian; Gabriel Medrano-Ramirez; Jorge L Morales-Torres; Frederick T Murphy; Theresa Kane Musser; Nicholas Straniero; Angela V Vicente-Gonzales; Elliott Grossbard
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.
Arthritis and rheumatism 2008;58(11):3309-18.
2008: Josef S Smolen; Michael E Weinblatt
When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
Annals of the rheumatic diseases 2008;67(11):1497-8.
2008: Michael E Weinblatt
Questions and answers in 2008 about biologics in rheumatoid arthritis.
The Journal of rheumatology 2008;35(9):1878-81.
2008: Sandeep K Agarwal; Roberta Glass; Nancy A Shadick; Jonathan S Coblyn; Ronald J Anderson; Nancy E Maher; Michael E Weinblatt; Daniel H Solomon
Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis.
The Journal of rheumatology 2008;35(9):1737-44.
2008: Joseph Lutt; Mary L Pisculli; Michael E Weinblatt; Atulya A Deodhar; Kevin L Winthrop
Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis.
The Journal of rheumatology 2008;35(8):1683-5.
2008: Soko Setoguchi; Sebastian Schneeweiss; Jerry Avorn; Jeffrey N Katz; Michael E Weinblatt; Raisa Levin; Daniel H Solomon
Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
American heart journal 2008;156(2):336-41.
2008: Michael E Weinblatt; Michael H Schiff; Eric M Ruderman; Clifton O Bingham; Juan Li; James Louie; Daniel E Furst
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
Arthritis and rheumatism 2008;58(7):1921-30.
2008: Derrick J Todd; Michael E Weinblatt
Oral versus parenteral administration of methotrexate for the treatment of active RA.
Nature clinical practice. Rheumatology 2008;4(7):342-3.
2008: Louise Royle; Matthew P Campbell; Catherine M Radcliffe; Dawn M White; David Harvey; Jodie L Abrahams; Yun-Gon Kim; George W Henry; Nancy A Shadick; Michael E Weinblatt; David M Lee; Pauline M Rudd; Raymond A Dwek
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.
Analytical biochemistry 2008;376(1):1-12.
2008: Elizabeth W Karlson; Lori B Chibnik; J Cui; Robert M Plenge; Roberta Glass; Nancy E Maher; A Parker; Ronenn Roubenoff; E Izmailova; Jonathan S Coblyn; Michael E Weinblatt; Nancy A Shadick
Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Annals of the rheumatic diseases 2008;67(3):358-63.
2008: Gladys Ting; Sebastian Schneeweiss; Richard Scranton; Jeffrey N Katz; Michael E Weinblatt; Melissa Young; Jerry Avorn; Daniel H Solomon
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study.
Arthritis research & therapy 2008;10(4):R95.
2007: Daniel E Furst; Ferdinand C Breedveld; JR Kalden; JS Smolen; Gerd R Burmester; J Sieper; P Emery; Edward C Keystone; Michael H Schiff; Philip J Mease; P L C M van Riel; Roy Fleischmann; Michael H Weisman; Michael E Weinblatt
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Annals of the rheumatic diseases 2007;66 Suppl 3():iii2-22.
2007: Nancy A Shadick; Jenny E Heller; Michael E Weinblatt; Nancy E Maher; J Cui; G Ginsburg; Jonathan S Coblyn; R Anderson; Daniel H Solomon; R Roubenoff; A Parker
Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(11):1497-502.
2007: Alex Parker; Elena S Izmailova; Jigna Narang; Sunita Badola; Tinh Le; Ronenn Roubenoff; Geoffrey S Ginsburg; Agnes Maier; Jonathan S Coblyn; Nancy A Shadick; Michael E Weinblatt
Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
The Journal of rheumatology 2007;34(9):1817-22.
2007: Gabriela Schmajuk; Sebastian Schneeweiss; Jeffrey N Katz; Michael E Weinblatt; Soko Setoguchi; Jerry Avorn; Raisa Levin; Daniel H Solomon
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
Arthritis and rheumatism 2007;57(6):928-34.
2007: Sebastian Schneeweiss; Soko Setoguchi; Michael E Weinblatt; Jeffrey N Katz; Jerry Avorn; Paul E Sax; Raisa Levin; Daniel H Solomon
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(6):1754-64.
2007: Michael E Weinblatt; Louis Kuritzky
RAPID: rheumatoid arthritis.
The Journal of family practice 2007;56(4 Suppl):S1-7; quiz S8.
2007: Daniel H Solomon; Margaret Stedman; Andrea Licari; Michael E Weinblatt; Nancy Maher; Nancy A Shadick
Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries.
Arthritis and rheumatism 2007;57(2):234-9.
2007: D J Todd; Karen H Costenbader; Michael E Weinblatt
Abatacept in the treatment of rheumatoid arthritis.
International journal of clinical practice 2007;61(3):494-500.
2007: Michael E Weinblatt; Michael Schiff; Allan Goldman; Joel Kremer; Michael Luggen; Tracy Li; Dalei Chen; Jean-Claude Becker
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
Annals of the rheumatic diseases 2007;66(2):228-34.
2006: Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Michael E Weinblatt; Soko Setoguchi; Raisa Levin; Sebastian Schneeweiss
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Arthritis and rheumatism 2006;54(12):3790-8.
2006: Daniel H Solomon; N J Goodson; Jeffrey N Katz; Michael E Weinblatt; Jerry Avorn; Soko Setoguchi; C Canning; Sebastian Schneeweiss
Patterns of cardiovascular risk in rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(12):1608-12.
2006: Christopher P Cannon; Sean P Curtis; garret fitzgerald; Henry Krum; Amarjot Kaur; James A Bolognese; Alise S Reicin; Claire Bombardier; Michael E Weinblatt; Désirée van der Heijde; Erland Erdmann; Loren Laine
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Lancet 2006;368(9549):1771-81.
2006: Michael E Weinblatt; P L C M van Riel
Targeted therapies: summary clinical trials working group.
Annals of the rheumatic diseases 2006;65 Suppl 3():iii89.
2006: Daniel E Furst; Ferdinand C Breedveld; JR Kalden; JS Smolen; Gerd R Burmester; P Emery; Edward C Keystone; Michael H Schiff; P L C M van Riel; Michael E Weinblatt; Michael H Weisman
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.
Annals of the rheumatic diseases 2006;65 Suppl 3():iii2-15.
2006: Soko Setoguchi; Daniel H Solomon; Michael E Weinblatt; Jeffrey N Katz; Jerry Avorn; Robert J Glynn; E Francis Cook; Greg Carney; Sebastian Schneeweiss
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.
Arthritis and rheumatism 2006;54(9):2757-64.
2006: Michael E Weinblatt; B Combe; A Covucci; R Aranda; Jean-Claude Becker; Edward C Keystone
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.
Arthritis and rheumatism 2006;54(9):2807-16.
2006: Alkes L Price; Nick Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Principal components analysis corrects for stratification in genome-wide association studies.
Nature genetics 2006;38(8):904-9.
2006: Elizabeth Benito-Garcia; Jenny E Heller; Lori B Chibnik; Nancy E Maher; Heather M Matthews; Jessica A Bilics; Michael E Weinblatt; Nancy A Shadick
Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
The Journal of rheumatology 2006;33(7):1275-81.
2006: Michael E Weinblatt; Edward C Keystone; Daniel E Furst; Arthur F Kavanaugh; Elliot K Chartash; Oscar Segurado
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.
Annals of the rheumatic diseases 2006;65(6):753-9.
2006: Larry W Moreland; Michael E Weinblatt; Edward C Keystone; Joel M Kremer; Richard W Martin; Michael H Schiff; James B Whitmore; Barbara A White
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
The Journal of rheumatology 2006;33(5):854-61.
2006: Erika H Noss; Dorota L Hausner-Sypek; Michael E Weinblatt
Rituximab as therapy for refractory polymyositis and dermatomyositis.
The Journal of rheumatology 2006;33(5):1021-6.
2006: Alyssa K Johnsen; Michael H Schiff; Philip J Mease; Larry W Moreland; agnes lee maier; Jonathan S Coblyn; Simon M Helfgott; Jonathan A Leff; Michael E Weinblatt
Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
The Journal of rheumatology 2006;33(4):659-64.
2006: Masayo Sato; Sebastian Schneeweiss; Richard Scranton; Jeffrey N Katz; Michael E Weinblatt; Jerry Avorn; Gladys Ting; Nancy A Shadick; Daniel H Solomon
The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.
Arthritis research & therapy 2006;8(3):R57.
2006: Michael H Schiff; Elaine B Yu; Michael E Weinblatt; Larry W Moreland; Mark C Genovese; Barbara A White; Amitabh Singh; Yun Chon; J Michael Woolley
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
Drugs & aging 2006;23(2):167-78.
2005: Sandeep K Agarwal; agnes lee maier; Lori B Chibnik; Jonathan S Coblyn; Anne H Fossel; Ryan Lee; John Fanikos; Karen Fiumara; Colleen Lowry; Michael E Weinblatt
Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center.
Arthritis and rheumatism 2005;53(6):872-8.
2005: Gladys Ting; Sebastian Schneeweiss; Jeffrey N Katz; Michael E Weinblatt; Danielle Cabral; Richard E Scranton; Daniel H Solomon
Performance of a rheumatoid arthritis records-based index of severity.
The Journal of rheumatology 2005;32(9):1679-87.
2005: Kristine Phillips; Michael E Weinblatt
Granulomatous lung disease occurring during etanercept treatment.
Arthritis and rheumatism 2005;53(4):618-20.
2005: Danielle Cabral; Jeffrey N Katz; Michael E Weinblatt; Gladys Ting; Jerry Avorn; Daniel H Solomon
Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel.
Arthritis and rheumatism 2005;53(1):61-6.
2004: Graciela S Alarcón; Joel Kremer; Michael E Weinblatt
Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: comment on the article by Yazici et al.
Arthritis and rheumatism 2004;50(8):2710; author reply 2710-1.
2004: Michael E Weinblatt
Rheumatoid arthritis: more aggressive approach improves outlook.
Cleveland Clinic journal of medicine 2004;71(5):409-13.
2003: Todd Ellerin; Robert Rubin; Michael E Weinblatt
Infections and anti-tumor necrosis factor alpha therapy.
Arthritis and rheumatism 2003;48(11):3013-22.
2003: Jeffrey P Callen; Gerald G Krueger; Mark Lebwohl; Elizabeth I McBurney; Philip J Mease; Alan Menter; Amy S Paller; David M Pariser; Michael E Weinblatt; Gail Zimmerman
AAD consensus statement on psoriasis therapies.
Journal of the American Academy of Dermatology 2003;49(5):897-9.
2003: Michael E Weinblatt
Rheumatoid arthritis in 2003: where are we now with treatment?
Annals of the rheumatic diseases 2003;62 Suppl 2():ii94-6.
2003: Daniel E Furst; Michael Weisman; Harold E Paulus; Ken J Bulpitt; Michael E Weinblatt; Richard Polisson; Michel Zaug; Johannes Kneer; Philippe Van der Auwera; Randall M Stevens
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
The Journal of rheumatology 2003;30(10):2123-6.
2003: Michael H Weisman; Larry W Moreland; Daniel E Furst; Michael E Weinblatt; Edward C Keystone; Harold E Paulus; Leah S Teoh; Raja B Velagapudi; Peter A Noertersheuser; G Richard Granneman; Steven Fischkoff; Elliot K Chartash
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Clinical therapeutics 2003;25(6):1700-21.
2003: Joel M Kremer; Michael E Weinblatt; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; Christopher G Jackson; Kelly M Atkins; Anyang Feng; Daniel J Burge
Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Arthritis and rheumatism 2003;48(6):1493-9.
2003: Isao Matsumoto; David M Lee; Raphaela Goldbach-Mansky; Takayuki Sumida; Carol A Hitchon; Peter H Schur; Ronald J Anderson; Jonathan S Coblyn; Michael E Weinblatt; Michael Brenner; Bernard Duclos; Jean-Louis Pasquali; Hani El-Gabalawy; Diane Mathis; Christophe Benoist
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.
Arthritis and rheumatism 2003;48(4):944-54.
2003: Michael E Weinblatt; Edward C Keystone; Daniel E Furst; Larry W Moreland; Michael H Weisman; Charles A Birbara; Leah A Teoh; Steven Fischkoff; Elliot K Chartash
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Arthritis and rheumatism 2003;48(1):35-45.
2002: M Elaine Husni; agnes lee maier; Philip J Mease; Steven S Overman; Patricia Fraser; Ellen M Gravallese; Michael E Weinblatt
Etanercept in the treatment of adult patients with Still's disease.
Arthritis and rheumatism 2002;46(5):1171-6.
2002: Désirée van der Heijde; Lee Simon; Josef Smolen; Vibeke Strand; John Sharp; Maarten Boers; Ferdinand Breedveld; Michael Weisman; Michael E Weinblatt; Rolf Rau; Peter Lipsky
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.
Arthritis and rheumatism 2002;47(2):215-8.
2002: Theodore Pincus; Allan Gibofsky; Michael E Weinblatt
Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists.
Arthritis and rheumatism 2002;46(4):851-4.
2002: Stanley Cohen; Eric Hurd; John J Cush; Michael Schiff; Michael E Weinblatt; Larry W Moreland; Joel Kremer; Moraye B Bear; William J Rich; Dorothy McCabe
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2002;46(3):614-24.
2002: Michael E Weinblatt
The best of times, the worst of times: rheumatology 2001.
Arthritis and rheumatism 2002;46(3):567-73.
2001: D M Lee; Michael E Weinblatt
Rheumatoid arthritis.
Lancet 2001;358(9285):903-11.
2001: Larry W Moreland; S B Cohen; Scott W Baumgartner; Elizabeth Tindall; Ken J Bulpitt; R Martin; Michael E Weinblatt; J Taborn; A Weaver; Daniel J Burge; Michael H Schiff
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
The Journal of rheumatology 2001;28(6):1238-44.
2000: Michael E Weinblatt; J A Dixon; K R Falchuk
Serious liver disease in a patient receiving methotrexate and leflunomide.
Arthritis and rheumatism 2000;43(11):2609-11.
2000: L A Mandl; R D Folkerth; M A Pick; Michael E Weinblatt; Ellen M Gravallese
Amyloid myopathy masquerading as polymyositis.
The Journal of rheumatology 2000;27(4):949-52.
1999: D E Furst; F C Breedveld; G R Burmester; L Crofford; P Emery; M Feldman; J R Kalden; A Kavanaugh; E Keystone; P E Lipsky; R N Maini; L Moreland; J S Smolen; L Van De Putte; T Vischer; Michael E Weinblatt; M Weissman
Access to disease modifying treatments for rheumatoid arthritis patients.
Annals of the rheumatic diseases 1999;58 Suppl 1():I129-30.
1999: Michael E Weinblatt; Domenic Reda; W Henderson; Anita Giobbie-Hurder; D Williams; A Diani; S Docsa
Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
The Journal of rheumatology 1999;26(10):2123-30.
1999: Michael E Weinblatt; Joel M Kremer; Jonathan S Coblyn; agnes lee maier; Simon M Helfgott; M Morrell; V M Byrne; M V Kaymakcian; Vibeke Strand
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Arthritis and rheumatism 1999;42(7):1322-8.
1999: Larry W Moreland; Michael H Schiff; Scott W Baumgartner; Elizabeth Tindall; Roy Fleischmann; Ken J Bulpitt; Arthur L Weaver; Edward C Keystone; Daniel E Furst; P J Mease; Eric M Ruderman; David A Horwitz; Daniel G Arkfeld; L Garrison; Daniel J Burge; CM Blosch; M L Lange; N D McDonnell; Michael E Weinblatt
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Annals of internal medicine 1999;130(6):478-86.
1999: Michael E Weinblatt; Joel M Kremer; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; R I Fox; C G Jackson; M Lange; Daniel J Burge
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
The New England journal of medicine 1999;340(4):253-9.
1998: Michael E Weinblatt; agnes lee maier; P A Fraser; Jonathan S Coblyn
Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
The Journal of rheumatology 1998;25(2):238-42.
1997: Joel M Kremer; Graciela S Alarcón; Michael E Weinblatt; M V Kaymakcian; M Macaluso; Grant W Cannon; W R Palmer; J S Sundy; E William St Clair; R W Alexander; G J Smith; C A Axiotis
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
Arthritis and rheumatism 1997;40(10):1829-37.
1997: Graciela S Alarcón; Joel M Kremer; M Macaluso; Michael E Weinblatt; Grant W Cannon; W R Palmer; E William St Clair; J S Sundy; R W Alexander; G J Smith; C A Axiotis
Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.
Annals of internal medicine 1997;127(5):356-64.
1997: Eric M Ruderman; J M Crawford; A Maier; J J Liu; Ellen M Gravallese; Michael E Weinblatt
Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis.
British journal of rheumatology 1997;36(2):210-3.
1996: Ellen M Gravallese; M L Handel; Jonathan S Coblyn; R J Anderson; R I Sperling; E W Karlson; A Maier; E M Ruderman; F Formelli; Michael E Weinblatt
N-[4-hydroxyphenyl] retinamide in rheumatoid arthritis: a pilot study.
Arthritis and rheumatism 1996;39(6):1021-6.
1996: Jeffrey N Katz; Elizabeth A Wright; K D Lynch; Michael E Weinblatt
Evaluation of two interventions to reduce the ancillary costs of outpatient care for rheumatoid arthritis.
Arthritis and rheumatism 1996;39(1):177-8.
1995: Michael E Weinblatt
Efficacy of methotrexate in rheumatoid arthritis.
British journal of rheumatology 1995;34 Suppl 2():43-8.
1995: Michael E Weinblatt; P J Maddison; Ken J Bulpitt; B L Hazleman; M B Urowitz; R D Sturrock; Jonathan S Coblyn; agnes lee maier; W R Spreen; V K Manna
CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.
Arthritis and rheumatism 1995;38(11):1589-94.
1995: S J Mandel; G A Brent; Michael E Weinblatt; P Reed Larsen
Prospective studies of thyroid function in patients receiving gold therapy.
Thyroid : official journal of the American Thyroid Association 1995;5(2):113-6.
1995: E M Ruderman; Michael E Weinblatt; L M Thurmond; Geraldine S Pinkus; Ellen M Gravallese
Synovial tissue response to treatment with Campath-1H.
Arthritis and rheumatism 1995;38(2):254-8.
1994: Michael E Weinblatt; H Kaplan; B F Germain; S Block; Scott D Solomon; R C Merriman; F Wolfe; B Wall; L Anderson; E Gall
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.
Arthritis and rheumatism 1994;37(10):1492-8.
1994: Michael E Weinblatt; B F Germain; Joel M Kremer; B A Wall; M H Weisman; agnes lee maier; Jonathan S Coblyn
Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial.
Arthritis and rheumatism 1994;37(9):1321-5.
1994: A M Reimold; Michael E Weinblatt
Tachyphylaxis of intravenous immunoglobulin in refractory inflammatory myopathy.
The Journal of rheumatology 1994;21(6):1144-6.
1993: Michael E Weinblatt; agnes lee maier; Jonathan S Coblyn
Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial.
The Journal of rheumatology 1993;20(6):950-2.
1993: Michael E Weinblatt; R Polisson; S D Blotner; J L Sosman; Piran Aliabadi; N Baker; B N Weissman
The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin.
Arthritis and rheumatism 1993;36(5):613-9.
1992: Michael E Weinblatt; Joel M Kremer; Jonathan S Coblyn; S Helfgott; agnes lee maier; G Petrillo; B Henson; P Rubin; R Sperling
Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
The Journal of rheumatology 1992;19(10):1537-41.
1992: R I Sperling; A I Benincaso; R J Anderson; Jonathan S Coblyn; K Frank Austen; Michael E Weinblatt
Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.
Arthritis and rheumatism 1992;35(4):376-84.
1992: Michael E Weinblatt; B N Weissman; D E Holdsworth; Patricia A Fraser; agnes lee maier; K R Falchuk; Jonathan S Coblyn
Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.
Arthritis and rheumatism 1992;35(2):129-37.
1991: Michael E Weinblatt; S Helfgott; Jonathan S Coblyn; J Spragg; W M Uedelhoven; S Tumeh; R Sperling; R Lorenz; A Maier; P Weber
The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis.
Arthritis and rheumatism 1991;34(4):481-5.
1991: Michael E Weinblatt; H Kaplan; B F Germain; R C Merriman; Scott D Solomon; B Wall; L Anderson; S Block; R Small; F Wolfe
Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study.
The Journal of rheumatology 1991;18(3):334-8.
1990: R I Sperling; Jonathan S Coblyn; J K Larkin; A I Benincaso; K Frank Austen; Michael E Weinblatt
Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.
Arthritis and rheumatism 1990;33(8):1149-55.
1990: Michael E Weinblatt; H Kaplan; B F Germain; R C Merriman; Scott D Solomon; B Wall; L Anderson; S Block; R Irby; F Wolfe
Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
Arthritis and rheumatism 1990;33(3):330-8.
1989: Michael E Weinblatt; P Fraser
Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy.
Arthritis and rheumatism 1989;32(12):1592-6.
1989: J Spragg; Jonathan S Coblyn; Patricia A Fraser; K F Austen; Michael E Weinblatt
The effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis.
Advances in experimental medicine and biology 1989;247A():389-92.
1989: J Spragg; N L Tilney; Michael E Weinblatt
Human renal kallikrein-kinin system after engraftment and/or immunosuppression.
Progress in clinical and biological research 1989;297():325-38.
1988: J Spragg; Michael E Weinblatt; Jonathan S Coblyn; P Fraser; K F Austen
Effect of cyclosporine on urinary kallikrein excretion in patients with rheumatoid arthritis.
The Journal of laboratory and clinical medicine 1988;112(3):324-32.
1988: Michael E Weinblatt; D E Trentham; Patricia A Fraser; D E Holdsworth; K R Falchuk; B N Weissman; Jonathan S Coblyn
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.
Arthritis and rheumatism 1988;31(2):167-75.
1988: Patricia A Fraser; S H Stern; Jonathan S Coblyn; Michael E Weinblatt; D E Holdsworth; P Green; S Shriner; D Mindnich; M Larson
Immunogenetic and racial determinants of gold toxicity in rheumatoid arthritis.
Journal of the National Medical Association 1988;80(2):162-5.
1987: R I Sperling; Michael E Weinblatt; J L Robin; J Ravalese; R L Hoover; F House; Jonathan S Coblyn; Patricia A Fraser; B W Spur; D R Robinson
Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis.
Arthritis and rheumatism 1987;30(9):988-97.
1987: Michael E Weinblatt; Patricia A Fraser; R Anderson; Jonathan S Coblyn; D E Trentham
Diminution of the T8 subset by amiprilose hydrochloride in refractory RA.
The Journal of rheumatology 1987;14(4):859-60.
1987: Michael E Weinblatt; Jonathan S Coblyn; Patricia A Fraser; R J Anderson; J Spragg; D E Trentham; K F Austen
Cyclosporin A treatment of refractory rheumatoid arthritis.
Arthritis and rheumatism 1987;30(1):11-7.
1985: Michael E Weinblatt; Jonathan S Coblyn; David A Fox; Patricia A Fraser; D E Holdsworth; D N Glass; D E Trentham
Efficacy of low-dose methotrexate in rheumatoid arthritis.
The New England journal of medicine 1985;312(13):818-22.
1984: Donald Raum; Zuheir L Awdeh; D Glass; G Kammer; M A Khan; Jonathan S Coblyn; Michael E Weinblatt; D Holdsworth; L Strong; Roger Rossen
Extended haplotypes of chromosome 6 in adult rheumatoid arthritis.
Arthritis and rheumatism 1984;27(5):516-21.